ARCHIVES

NIH Panel Calls for Further Research On End-of-Life Issues.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Panel Says Tamoxifen Remains Standard for Preventing Breast Cancer

May 24, 2002

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

January 2, 1981

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Byrd Seeks Federal Tar-Nicotine Limit

October 22, 1976